Skip to main content
Erschienen in: Journal of Cancer Education 4/2013

01.12.2013

Barriers and Facilitators to Adherence to Screening Colonoscopy Among African-Americans: a Mixed-Methods Analysis

verfasst von: Carrie R. Wong, Elana R. Bloomfield, Danielle M. Crookes, Lina Jandorf

Erschienen in: Journal of Cancer Education | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

This mixed-methods study reports barriers and facilitators to screening colonoscopy among inner-city African-Americans. A purposive sample of 29 African-Americans ≥50 years old with average risk of colorectal cancer (CRC) was recruited from CRC education programs in an urban setting (June 2011–April 2012). A demographic survey collected quantitative data (e.g., socioeconomic status), and a semi-structured interview assessed qualitative data (e.g., perspectives of colonoscopies). Sample and between-group analyses were conducted using descriptive statistics and content analysis of quantitative and qualitative data, respectively. The sample consisted of 17 people who completed a colonoscopy and 12 who had not. Mean age was 68 years; 79 % completed at least high school, and all had health care coverage and had visited a physician within the last year. Physician recommendation was prevalent among both groups (15/17 in completers vs. 8/12 in non-completers) and thus did not fully explain the differences in adherence. The greatest barrier for the non-colonoscopy group was lack of knowledge about the importance of screening while the commonest facilitator for the colonoscopy group was physician recommendation. Improved knowledge about colonoscopies is a significant facilitator to adherence, while physician recommendation was not significantly different between groups. Promotion of screening colonoscopies by both physicians and community programs has the potential to improve adherence rates in the African-American population.
Literatur
1.
Zurück zum Zitat Agrawal S, Bhupinderjit A, Bhutani MS et al (2005) Colorectal cancer in African Americans. Am J Gastroenterol 100:515–523CrossRefPubMed Agrawal S, Bhupinderjit A, Bhutani MS et al (2005) Colorectal cancer in African Americans. Am J Gastroenterol 100:515–523CrossRefPubMed
2.
Zurück zum Zitat American Cancer Society (2012) Cancer facts and figures 2012. American Cancer Society, Atlanta American Cancer Society (2012) Cancer facts and figures 2012. American Cancer Society, Atlanta
3.
Zurück zum Zitat Christie J, Itzkowitz S, Lihau-Nkanza I et al (2008) A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc 100:278–284PubMed Christie J, Itzkowitz S, Lihau-Nkanza I et al (2008) A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc 100:278–284PubMed
6.
Zurück zum Zitat Edwards BK, Ward E, Kohler BA et al (2010) Annual Report to the Nation on the Status of Cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573PubMedCentralCrossRefPubMed Edwards BK, Ward E, Kohler BA et al (2010) Annual Report to the Nation on the Status of Cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Guessous I, Dash C, Lapin P et al (2012) Colorectal cancer screening barriers and facilitators in older persons. Prev Med 50:3–10CrossRef Guessous I, Dash C, Lapin P et al (2012) Colorectal cancer screening barriers and facilitators in older persons. Prev Med 50:3–10CrossRef
8.
Zurück zum Zitat Hsia J, Kemper E, Kiefe C et al (2000) The importance of health insurance as a determinant of cancer screening: evidence from the Women’s Health Initiative. Prev Med 31:261–270CrossRefPubMed Hsia J, Kemper E, Kiefe C et al (2000) The importance of health insurance as a determinant of cancer screening: evidence from the Women’s Health Initiative. Prev Med 31:261–270CrossRefPubMed
9.
Zurück zum Zitat Hsieh H, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15:1277–1288CrossRefPubMed Hsieh H, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15:1277–1288CrossRefPubMed
10.
Zurück zum Zitat Jandorf L, Gutierrez Y, Lopez J et al (2005) Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health 82:216–224PubMedCentralCrossRefPubMed Jandorf L, Gutierrez Y, Lopez J et al (2005) Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health 82:216–224PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Klabunde CN, Schenck AP, Davis WW (2006) Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 30:313–319CrossRefPubMed Klabunde CN, Schenck AP, Davis WW (2006) Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 30:313–319CrossRefPubMed
12.
Zurück zum Zitat Lafata JE, Divine G, Moon C et al (2006) Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med 31:202–209CrossRefPubMed Lafata JE, Divine G, Moon C et al (2006) Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med 31:202–209CrossRefPubMed
13.
Zurück zum Zitat Lebwohl B, Neugut AI, Stavsky E et al (2011) Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol 45:e47–e53PubMedCentralCrossRefPubMed Lebwohl B, Neugut AI, Stavsky E et al (2011) Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol 45:e47–e53PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Odelowo OO, Hoque M, Begum R et al (2002) Colonoscopy for colorectal cancer screening in African Americans. J Assoc Acad Minor Phys 13:66–68PubMed Odelowo OO, Hoque M, Begum R et al (2002) Colonoscopy for colorectal cancer screening in African Americans. J Assoc Acad Minor Phys 13:66–68PubMed
16.
Zurück zum Zitat Percac-Lima S, Grant RW, Green AR et al (2009) A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med 24:211–217PubMedCentralCrossRefPubMed Percac-Lima S, Grant RW, Green AR et al (2009) A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med 24:211–217PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Phipps AI, Scoggins J, Rossing MA et al (2012) Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975–2007. Am J Public Health 102:1791–1797PubMedCentralCrossRefPubMed Phipps AI, Scoggins J, Rossing MA et al (2012) Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975–2007. Am J Public Health 102:1791–1797PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Rex DK, Johnson DA, Anderson JC et al (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 104:739–750CrossRefPubMed Rex DK, Johnson DA, Anderson JC et al (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 104:739–750CrossRefPubMed
19.
Zurück zum Zitat Shavers VL, Jackson MC, Sheppard VB (2010) Racial/ethnic patterns of uptake of colorectal screening, National Health Interview Survey 2000–2008. J Natl Med Assoc 102:621–635PubMed Shavers VL, Jackson MC, Sheppard VB (2010) Racial/ethnic patterns of uptake of colorectal screening, National Health Interview Survey 2000–2008. J Natl Med Assoc 102:621–635PubMed
20.
21.
Zurück zum Zitat Smith RA, Cokkinides V, Brawley OW (2012) Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 62:129–142CrossRefPubMed Smith RA, Cokkinides V, Brawley OW (2012) Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 62:129–142CrossRefPubMed
22.
Zurück zum Zitat Turner BJ, Weiner M, Yang C et al (2004) Predicting adherence to colonoscopy or flexible sigmoidoscopy on the basis of physician appointment-keeping behavior. Ann Intern Med 140:528–532CrossRefPubMed Turner BJ, Weiner M, Yang C et al (2004) Predicting adherence to colonoscopy or flexible sigmoidoscopy on the basis of physician appointment-keeping behavior. Ann Intern Med 140:528–532CrossRefPubMed
23.
Zurück zum Zitat Wee CC, McCarthy EP, Phillips RS (2005) Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41:23–29CrossRefPubMed Wee CC, McCarthy EP, Phillips RS (2005) Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41:23–29CrossRefPubMed
Metadaten
Titel
Barriers and Facilitators to Adherence to Screening Colonoscopy Among African-Americans: a Mixed-Methods Analysis
verfasst von
Carrie R. Wong
Elana R. Bloomfield
Danielle M. Crookes
Lina Jandorf
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2013
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-013-0510-0

Weitere Artikel der Ausgabe 4/2013

Journal of Cancer Education 4/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.